Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary

Update: On February 3, 2017, the Cystic Fibrosis Foundation divested its remaining ownership stake in CF Services Inc., a specialty pharmacy. The pharmacy is now fully owned by Walgreens.

| 4 min read

(Bethesda, MD) -- Cystic Fibrosis Services, Inc., a wholly owned subsidiary of the Cystic Fibrosis Foundation, today announced its 20th anniversary of providing quality pharmacy services to the cystic fibrosis (CF) community nationwide.

The organization was founded in 1988 with one patient, one prescription and a mission to improve access to specialty medications for people with CF. It met an untapped need and had 1,300 customers within six months. Today, the pharmacy has filled more than one million prescriptions and provides services to nearly 8,000 customers -- almost one-third of the entire CF population in the United States.

“The CF Services Pharmacy has a 20-year track record of advocating for people with cystic fibrosis and removing barriers that stand in the way of people receiving the drugs and therapies they need to stay healthy,” said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation.

In addition to competitively priced medications, CF Services provides many free services unavailable at other pharmacies. These include help with insurance reimbursement, monthly billing (rather than upfront payment), specialty supplies and equipment at no charge, and financial assistance for those in need. The pharmacy provides more than $1 million in assistance and support annually to customers and the CF community.

“We are honored to have helped and served so many people with cystic fibrosis over the past two decades,” said Dan Klein, vice president and general manager of CF Services. “As important new CF therapies become available in the coming years, we are poised to tackle whatever obstacles stand in the way of patients receiving the best CF drugs available.”

CF Services has also played an important role in helping pharmaceutical companies set up patient assistance programs, and in funding patient education programs at CF Foundation-accredited care centers and fundraising chapters.

CF is a life-threatening genetic disease that affects approximately 30,000 people in the United States. It causes the body to produce abnormally thick mucus that leads to debilitating lung infections and digestion complications. When the CF Foundation was created in 1955, few children lived to attend elementary school. Today, because of research and care supported by the CF Foundation, the median age of survival for a person with CF is now age 37.

About CF Services 

CF Services Inc., a wholly owned subsidiary of the Cystic Fibrosis Foundation, was established in 1988 as a specialty pharmacy in response to CF patients' need for quality pharmacy services. Today, CF Services continues this mission. CF Services understands that CF is complicated and getting your medication shouldn't be! For more information, visit the CF Services website.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The CF Foundation funds more cystic fibrosis research than any other organization, and nearly every CF drug available today was made possible because of CF Foundation support. Based in Bethesda, Md., the CF Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. The Cystic Fibrosis Foundation is a donor-supported nonprofit organization.  

Media Contact

Laurie Fink, director of media relations: 301-841-2602lfink@cff.org 

Share this article
Topics
About the CF Foundation
Recent news
Nearly 350 Advocates Urge Congressional Action During 17th Annual March on the Hill
News | 3 min read
Cystic Fibrosis Foundation Invests an Additional $5 Million in BiomX
News | 2 min read
Cystic Fibrosis Foundation Invests More Than $6.6 Million in Additional Funding in Sionna Therapeutics
News | 2 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe